← Back to screener

NeuroPace Inc NPCE

Rank #2465 · Nasdaq · $0.4B market cap
Audited by PricewaterhouseCoopers, no going-concern flag in the latest filing.
Score
16.0
P/E
-15.5
P/B
20.30
ROE
-131.4%
Op. Margin
-27.1%
Debt Ratio
419%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -15.5x, P/B 20.30x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -131.4%. Ranks in the top 89% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 419%. Ranks in the top 77% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 22.1% year over year. Ranks in the top 17% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021$0.0B$-0.0B$-0.0B$-0.1B-31.7-48
2022$0.0B$-0.0B$-0.0B$-0.1B-52.5-41
2023$0.0B$-0.0B$-0.0B$0.1B-89.6108
2024$0.1B$-0.0B$-0.0B$0.0B-41.5250
2025$0.1B$-0.0B$-0.0B$0.0B-27.1419

← See the full screener